Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysis

Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysis

Stefan Borgmann,1 Beate Rieß,1 Rabea Siegmund,1 Guido Werner,2 Ingo Klare2 1Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany; 2National Reference Centre for Staphylococci and Enterococci, Robert Koch Institute, Wernigerode Branch, Wernigero...

Full description

Bibliographic Details
Main Authors: Borgmann S, Rieß B, Siegmund R, Werner G, Klare I
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Microbiota
oligoclonal spread
outbreak
probiotics
vanB
Online Access:https://www.dovepress.com/treatment-with-saccharomyces-boulardii-and-escherichia-coli-nissle-is--peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/treatment-with-saccharomyces-boulardii-and-escherichia-coli-nissle-is--peer-reviewed-article-TCRM

Similar Items